CUAMC
China Universal Asset Management Company Portfolio holdings
AUM
$1.06B
This Quarter Return
+18.02%
1 Year Return
+31.81%
3 Year Return
+205.04%
5 Year Return
–
10 Year Return
–
AUM
$1.06B
AUM Growth
+$1.06B
(-1.1%)
Cap. Flow
-$150M
Cap. Flow
% of AUM
-14.08%
Top 10 Holdings %
Top 10 Hldgs %
37.54%
Holding
501
New
15
Increased
263
Reduced
171
Closed
24
Top Buys
| 1 |
SPDR Gold Trust
GLD
|
$6.59M |
| 2 |
iShares Gold Trust Micro
IAUM
|
$4.62M |
| 3 |
Intuit
INTU
|
$3.73M |
| 4 |
SPDR Gold MiniShares Trust
GLDM
|
$3.6M |
| 5 |
T-Mobile US
TMUS
|
$2.35M |
Top Sells
| 1 |
Apple
AAPL
|
$17.4M |
| 2 |
NVIDIA
NVDA
|
$12.2M |
| 3 |
Microsoft
MSFT
|
$11.5M |
| 4 |
Amazon
AMZN
|
$8.86M |
| 5 |
Broadcom
AVGO
|
$8.43M |
Sector Composition
| 1 | Technology | 38.15% |
| 2 | Healthcare | 22.68% |
| 3 | Communication Services | 12.64% |
| 4 | Consumer Discretionary | 11.62% |
| 5 | Consumer Staples | 3.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
226
TJX Companies
TJX
$155B
| $614K | 0.06% |
4,970
| – | – |
|
227
TAL Education Group
TAL
$6.39B
| $607K | 0.06% |
59,400
-80,600
| -58% | -$824K |
|
228
Wave Life Sciences
WVE
$1.53B
| $607K | 0.06% |
93,370
+40,850
| +78% | +$266K |
|
229
Legend Biotech
LEGN
$6.32B
| $582K | 0.05% |
16,406
+21
| +0.1% | +$745 |
|
230
Procept Biorobotics
PRCT
$2.2B
| $576K | 0.05% |
+10,000
| New | +$576K |
|
231
Ocular Therapeutix
OCUL
$2.21B
| $575K | 0.05% |
61,995
+30,460
| +97% | +$283K |
|
232
IQVIA
IQV
$31.2B
| $552K | 0.05% |
3,500
| – | – |
|
233
Immunovant
IMVT
$2.63B
| $549K | 0.05% |
34,329
+258
| +0.8% | +$4.13K |
|
234
Crinetics Pharmaceuticals
CRNX
$3.14B
| $541K | 0.05% |
18,815
+151
| +0.8% | +$4.34K |
|
235
XPeng
XPEV
$19.8B
| $536K | 0.05% |
30,000
-2,000
| -6% | -$35.8K |
|
236
CDW
CDW
$21.3B
| $534K | 0.05% |
2,990
-282
| -9% | -$50.4K |
|
237
Invesco QQQ Trust
QQQ
$361B
| $525K | 0.05% |
950
+360
| +61% | +$199K |
|
238
Ferrari
RACE
$87.7B
| $510K | 0.05% |
1,039
-200
| -16% | -$98.1K |
|
239
Amneal Pharmaceuticals
AMRX
$3.01B
| $509K | 0.05% |
62,949
+775
| +1% | +$6.27K |
|
240
Mirum Pharmaceuticals
MIRM
$3.73B
| $506K | 0.05% |
9,949
+118
| +1% | +$6.01K |
|
241
Arm
ARM
$140B
| $491K | 0.05% |
3,037
-197
| -6% | -$31.9K |
|
242
Alvotech
ALVO
$2.48B
| $489K | 0.05% |
53,590
-6,882
| -11% | -$62.8K |
|
243
Xenon Pharmaceuticals
XENE
$3.03B
| $482K | 0.05% |
15,412
+59
| +0.4% | +$1.85K |
|
244
GlobalFoundries
GFS
$18.4B
| $480K | 0.05% |
12,554
-1,096
| -8% | -$41.9K |
|
245
ImmunityBio
IBRX
$2.25B
| $468K | 0.04% |
177,271
+30,813
| +21% | +$81.3K |
|
246
Twist Bioscience
TWST
$1.58B
| $443K | 0.04% |
12,034
+69
| +0.6% | +$2.54K |
|
247
Ligand Pharmaceuticals
LGND
$3.19B
| $441K | 0.04% |
3,875
+13
| +0.3% | +$1.48K |
|
|
HSAI
248
Hesai Group
HSAI
$3.31B
| $439K | 0.04% |
20,000
-43,000
| -68% | -$944K |
|
249
Arrowhead Research
ARWR
$3.55B
| $438K | 0.04% |
27,737
+2,444
| +10% | +$38.6K |
|
250
Apellis Pharmaceuticals
APLS
$3.56B
| $437K | 0.04% |
25,243
+67
| +0.3% | +$1.16K |
|